Article
Common Variant in TREM1 Influencing Brain Amyloid Deposition in Mild Cognitive Impairment and Alzheimer's Disease.
Neurotoxicity research - 1 Mar 2020
Liu Yue-Song, Yan Wen-Jing, Tan Chen-Chen, Li Jie-Qiong, Xu Wei, Cao Xi-Peng, Tan Lan, Yu Jin-Tai
Abstract excerpt
Triggering receptor expressed on myeloid cells-1 (TREM1) has been reported to associate with Alzheimer's disease (AD) pathology. Recently, TREM1 variant rs2234246A was reported to regulate TREM-1 protein and mRNA levels. We explored the effect of rs2234246 on AD specific biomarker (amyloid-β PET) to look into the role of this TREM1 locus in AD pathogenesis. We calculated the association of the TREM1 locus with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
